New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks

Published:2021-11 Issue:4 Volume:14 Page:262-264
ISSN:1756-5383
Container-title:Journal of Evidence-Based Medicine
language:en
Short-container-title:J Evidence Based Medicine

Author:

Xu Xiang¹,Bi Yan¹^ORCID

Affiliation:

1. Department of Endocrinology, Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School Nanjing China

Publisher

Wiley

Subject

Health Policy,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jebm.12452

Reference19 articles.

1. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study

2. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

3. Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study

4. Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review

5. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP